Dec 18, 2020 8:30am EST Medexus Enters into Exclusive License to Register and Commercialize Triamcinolone Hexacetonide (TH) in the United States with Ethypharm
Dec 08, 2020 8:30am EST Medexus to Present at The 13th Annual LD Micro Main Event Conference on December 15th
Nov 16, 2020 5:15pm EST Medexus Pharmaceuticals Reports Operating and Financial Results for the Three- and Six-Month Periods Ending September 30, 2020
Nov 16, 2020 8:00am EST Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients
Oct 30, 2020 12:30pm EDT Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
Sep 25, 2020 8:30am EDT Medexus Appoints Michael Pine as Senior Vice President of Business Development and Strategy
